New risk factors for donor site seroma formation after latissimus dorsi flap breast reconstruction: 10-year period outcome analysis

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 64, Issue 1, 2011, Pages 69-74

  Gruber, Sabine ^a   Whitworth, Alexandra B ^a   Kemmler, Georg ^b   Papp, Christoph ^c  

^a Barmherzige Brüder Salzburg Hospital   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c Dr Pierer Clinic   (Austria)

Author keywords

Breast reconstruction; Ca level; Latissimus dorsi flap; Outcome analysis; Seroma risk factors; SSRI

Indexed keywords

SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;

ADULT; ARTICLE; ASPIRATION; BODY MASS; BREAST RECONSTRUCTION; CALCIUM BALANCE; CANCER RISK; CLINICAL ARTICLE; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; DONOR SITE; DRUG USE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; LATISSIMUS DORSI FLAP; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROMA; SURGICAL TECHNIQUE; TUMOR VOLUME;

ADULT; AGE DISTRIBUTION; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; COHORT STUDIES; DRAINAGE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INCIDENCE; LINEAR MODELS; MALE; MAMMAPLASTY; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE, SKELETAL; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEROMA; SURGICAL FLAPS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650418329     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2010.03.032     Document Type: Article

References (24)

1. G.P. Maxwell Iginio Tansini and the origin of the latissimus dorsi musculocutaneous flap Plast Reconstr Surg 65 1980 686
2. J.B. McCraw, C. Papp, and A. Edwards The autogenous latissimus breast reconstruction Clin Plast Surg 21 1994 279 288
3. C. Papp, and J.B. McCraw Autogenous latissimus breast reconstruction Clin Plast Surg 25 1998 261
4. C. Papp, E. Zanon, and J.B. McCraw Breast volume replacement using the de-epithelialized latissimus dorsi myocutaneous flap Eur J Plast Surg 11 1988 120
5. E. Delay, N. Gounot, and A. Bouillot Autologous latissimus breast reconstruction: a 3-year clinical experience with 100 patients Plast Reconstr Surg 102 1998 1461
6. D.W. Chang, A. Youssef, and S. Cha Autologous breast reconstruction with the extended latissimus dorsi flap Plast Reconstr Surg 110 2002 751
7. I. Reddick Seroma after latissimus dorsi myocutaneous flap for breast reconstruction Plast Reconstr Surg 85 1990 826
8. A. Schwabegger, M. Ninkovic, and E. Brenner Seroma as a common donor site morbidity after harvesting the latissimus dorsi flap: observation on cause and prevention Ann Plast Surg 38 1997 594
9. O.G. Titley, G.E. Spyrou, and M.F. Fatha Preventing seroma in the latissimus dorsi flap donor site Br J Plast Surg 50 1997 106 108
10. J.C. Weinrach, E.D. Cronin, and B.K. Smith Preventing seroma in the latissimus dorsi flap donor site with fibrin sealant Ann Plast Surg 53 2004 12 16
11. I. Daltrey, H. Thomson, and M. Hussien Randomized clinical trial of the effect of quilting latissimus flap donor site on seroma formation Br J Plast Surg 93 2006 825 830
12. B.H. Chang, and S. Pocock Analyzing data with clumping at zero: an example demonstration J Clin Epidemiol 53 2000 1036 1043
13. D.W. Chang, B. Wang, and G.L. Robb Effect of obesity on flap and donor-site complications in free transverse rectus abdominis myocutaneous flap breast reconstruction Plast Reconstr Surg 105 2000 1640 1648
14. J.E. Lipa, A.A. Youssef, and H.M. Kuerer Breast reconstruction in older women: advantages of autogenous tissue Plast Reconstr Surg 111 2003 1110 1121
15. D.W. Chang, G.P. Reece, and B. Wang Effect of smoking on complications in patients undergoing free TRAM breast reconstruction Plast Reconstr Surg 105 2000 2374 2380
16. B.J. Mehrara, T.D. Santoro, and E. Arcilla Complication after microvascular breast reconstruction: experience with 1195 flaps Plast Reconstr Surg 118 2006 1100 1109
17. B.P. Skop, and T.M. Brown Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors Psychosomatics 37 1996 12 16
18. C.P. Alderman, P. Seshadri, and D.I. Ben-Tovim Effects of serotonin reuptake inhibitors on hemostasis Ann Pharmacother 30 1996 1232 1234
19. R.M. Weinrieb, M. Auriacombe, and K.G. Lynch Selective serotonin re-uptake inhibitors and the risk of bleeding Expert Opin Drug Saf 4 2005 337 344
20. V.L. Serebruany Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? Am J Med 119 2006 113 116
21. N. Kotzailias, T. Andonovski, and A. Dukic Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirine in male smokers: a randomized, placebo-controlled, double-blind trial J Clin Pharmacol 46 2006 468 475
22. Y. Yuan, K. Tsoi, and R.H. Hunt Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med 119 2006 719 727
23. W.E. Meijer, M.L. Bouvy, and E.R. Heerdink Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors Br J Psychiatry 179 2001 519 522
24. P.M. Haddad Antidpressant discontinuation syndromes: clinical relevance, prevention and management Drug Saf 24 2001 183 197